Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 10/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.45 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.38 |
| ▸ | GABRP | O00591 | 2/20 | 0.36 |
| ▸ | GABRD | O14764 | 2/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.36 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.36 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL642105 | 1.00 | HCAR2 (0.54) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL642104 | 1.00 | HCAR2 (0.54) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Ethane SCHEMBL17667147 | 0.98 | HCAR2 (0.52) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Methane SCHEMBL9860828 | 0.98 | HCAR2 (0.52) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL28920930 | 0.98 | HCAR2 (0.52) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Ethane SCHEMBL29288096 | 0.98 | HCAR2 (0.52) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Propane SCHEMBL7780510 | 0.93 | HCAR2 (0.54) | HCAR2TSHRTP53EGLN1EGLN3 | |
| Cyclohexane SCHEMBL10616072 | 0.93 | HCAR2 (0.48) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL8405431 | 0.89 | HCAR2 (0.45) | HCAR2TSHRTP53EGLN1EGLN3 | |
| SCHEMBL8405432 | 0.89 | HCAR2 (0.45) | HCAR2TSHRTP53EGLN1EGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 322 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210179533-A1 | SALICYL FUMARATE DERIVATIVE AND ITS APPLICATION IN THE TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES | CHONGQING NEUROPARK BIOSCIENCE CO., LTD. (CN) | 2021-06-17 | — | — | US | claimed |
| EP-3611157-A1 | SALICYLIC ACID-BASED FUMARATE DERIVATIVE AND USE IN TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES | Chongqing Neuropark Bioscience Co., Ltd. (CN) | 2020-02-19 | — | — | EP | claimed |
| US-20200048182-A1 | A SALICYL FUMARATE DERIVATIVE AND ITS APPLICATION IN THE TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES | CHONGQING NEUROPARK BIOSCIENCE CO., LTD. (CN) | 2020-02-13 | — | — | US | claimed |
| EP-3208301-B1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | TOSOH CORP (JP) | 2019-04-03 | — | — | EP | claimed |
| US-10126478-B2 | Resin composition and optical compensation film using same | TOSOH CORPORATION (JP) | 2018-11-13 | — | — | US | claimed |
| US-20170242174-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | TOSOH CORPORATION (JP) | 2017-08-24 | — | — | US | claimed |
| EP-3208301-A1 | RESIN COMPOSITION AND OPTICAL COMPENSATION FILM USING SAME | Tosoh Corporation (JP) | 2017-08-23 | — | — | EP | claimed |
| US-6306990-B1 | MALEIC ACID DIESTER MONOMERS FOR POLYMER FILMS AND HEAT STABLE POLYMERS | SIEMENS AKTIENGESELLSCHAFT (DE) | 2001-10-23 | — | — | US | claimed |
| EP-0955562-A1 | Chemically amplified resist | SIEMENS AKTIENGESELLSCHAFT (DE) | 1999-11-10 | — | — | EP | claimed |
| EP-0494383-B1 | photoresist | SIEMENS AG (DE) | 1996-08-14 | — | — | EP | claimed |
| EP-0494383-A1 | Photoresist | SIEMENS AKTIENGESELLSCHAFT (DE) | 1992-07-15 | — | — | EP | claimed |
| JP-11140132-A | — | — | None | — | — | JP | disclosed |
| CN-113441364-B | Flow dip coating method and flow dip coating apparatus | 富士胶片商业创新有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-4731627-A1 | IMIDAZO[1,2-A]PYRAZIN DERIVATIVES AND THEIR USE IN THE TREATMENT OF A HELMINTH INFECTION | Merck Patent GmbH (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4724417-A1 | TRICINE AND CITRIC ACID-BASED CATIONIC LIPIDS WITH AROMATIC HEAD GROUPS | Sanofi (FR) | 2026-04-15 | — | — | EP | disclosed |
| US-4056653-A | CARBOXYLIC ACID COPOLYMER RESINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-11-01 | — | — | US | disclosed |
| US-4056208-A | Caustic-resistant polymer coatings for glass | PREJEAN GEORGE WYATT | 1977-11-01 | — | — | US | disclosed |
| US-4048130-A | COPOLYMERIZATION, UNSATURATED ACIDS | LONZA LTD. (CH) | 1977-09-13 | — | — | US | disclosed |
| US-3959539-A | POWDER | E. I. DU PONT DE NEMOURS AND COMPANNY (US) | 1976-05-25 | — | — | US | disclosed |
| US-3933954-A | CARBOXYLIC ACID COPOLYMER RESINS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210179533-A1 | SALICYL FUMARATE DERIVATIVE AND ITS APPLICATION IN THE TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES | FH, SUCNR1, SDHB | HCAR2 61/4885TSHR 3480/4885TP53 2118/4885 |
| US-20200048182-A1 | A SALICYL FUMARATE DERIVATIVE AND ITS APPLICATION IN THE TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES | FH, SUCNR1, SDHB | HCAR2 75/4885TSHR 3371/4885TP53 2085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.